These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36288935)

  • 1. Predictive Value of N-Terminal Pro B-Type Natriuretic Peptide for Contrast-Induced Nephropathy Non-Recovery and Poor Outcomes Among Patients Undergoing Percutaneous Coronary Intervention.
    Luo M; Zhu Z; Zhang L; Zhang S; You Z; Chen H; Rao J; Lin K; Guo Y
    Circ J; 2023 Jan; 87(2):258-265. PubMed ID: 36288935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does N-terminal pro-brain natriuretic peptide add prognostic value to the Mehran risk score for contrast-induced nephropathy and long-term outcomes after primary percutaneous coronary intervention?
    Liu YH; Jiang L; Chen JY; Tan N; Liu Y; He PC
    Int Urol Nephrol; 2016 Oct; 48(10):1675-82. PubMed ID: 27473154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between N-terminal pro-brain natriuretic peptide levels and contrast-induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome.
    Kurtul A; Duran M; Yarlioglues M; Murat SN; Demircelik MB; Ergun G; Acikgoz SK; Sensoy B; Cetin M; Ornek E
    Clin Cardiol; 2014 Aug; 37(8):485-92. PubMed ID: 24805995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of N-terminal pro-B-type natriuretic peptide with contrast-induced nephropathy and long-term outcomes in patients with chronic kidney disease and relative preserved left ventricular function.
    Liu YH; Liu Y; Zhou YL; Yu DQ; He PC; Xie NJ; Li HL; Wei-Guo ; Chen JY; Tan N
    Medicine (Baltimore); 2015 Apr; 94(13):e358. PubMed ID: 25837748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preprocedural N-terminal pro-brain natriuretic peptide (NT-proBNP) is similar to the Mehran contrast-induced nephropathy (CIN) score in predicting CIN following elective coronary angiography.
    Liu Y; He YT; Tan N; Chen JY; Liu YH; Yang DH; Huang SJ; Ye P; Li HL; Ran P; Duan CY; Chen SQ; Zhou YL; Chen PY
    J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25888371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-Terminal Fragment of Pro B-type Natriuretic Peptide as a Marker of Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction.
    Goussot S; Mousson C; Guenancia C; Stamboul K; Brunel P; Brunet D; Touzery C; Cottin Y; Zeller M
    Am J Cardiol; 2015 Sep; 116(6):865-71. PubMed ID: 26183794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-Procedural N-Terminal Pro-B Type Natriuretic Peptide Predicts Contrast-Induced Acute Kidney Injury and Long-Term Outcome in Elderly Patients After Elective Percutaneous Coronary Intervention.
    Lin KY; Wu ZY; You ZB; Zheng WP; Lin CJ; Jiang H; Ruan JM; Guo YS; Zhu PL
    Int Heart J; 2018 Sep; 59(5):926-934. PubMed ID: 30158378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of baseline N-terminal pro-B-type natriuretic peptide with short and long-term prognosis following percutaneous coronary intervention in non-ST segment elevation acute coronary syndrome with multivessel coronary artery disease: a retrospective cohort study.
    He WF; Jiang L; Chen YY; Liu YH; Chen PY; Duan CY; Zeng LH; Fan HL; Wei XB; Guo W; Chen W; Li J; Li WS; Guo ZQ; Liu ZK; Tan N; Chen JY; He PC
    BMC Cardiovasc Disord; 2021 Apr; 21(1):202. PubMed ID: 33882836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of systemic immune-inflammation index combined with N-terminal pro-brain natriuretic peptide for contrast-induced acute kidney injury in patients with STEMI after primary PCI.
    Shen G; He H; Zhang X; Wang L; Wang Z; Li F; Lu Y; Li W
    Int Urol Nephrol; 2024 Mar; 56(3):1147-1156. PubMed ID: 37658947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of preprocedural albuminuria for contrast-induced nephropathy non-recovery in patients undergoing percutaneous coronary intervention.
    Chen H; You Z; Zhang S; He C; He H; Luo M; Lin X; Zhang L; Lin K; Guo Y
    Int Urol Nephrol; 2021 Dec; 53(12):2603-2610. PubMed ID: 33675474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal pro-brain natriuretic peptide and coronary collateral formation in patients undergoing primary percutaneous coronary intervention.
    Park BE; Lee JH; Kim HJ; Kim HN; Jang SY; Bae MH; Yang DH; Park HS; Cho Y; Chae SC
    Heart Vessels; 2021 Dec; 36(12):1775-1783. PubMed ID: 34047816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early discharge after primary percutaneous coronary intervention: the added value of N-terminal pro-brain natriuretic peptide to the Zwolle Risk Score.
    Schellings DA; Adiyaman A; Giannitsis E; Hamm C; Suryapranata H; Ten Berg JM; Hoorntje JC; Van't Hof AW
    J Am Heart Assoc; 2014 Nov; 3(6):e001089. PubMed ID: 25389283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CHA2DS2-VASC score as a preprocedural predictor of contrast-induced nephropathy among patients with chronic total occlusion undergoing percutaneous coronary intervention: a single-center experience.
    Wang Y; Zhao HW; Zhang XJ; Chen BJ; Yu GN; Hou AJ; Luan B
    BMC Cardiovasc Disord; 2019 Mar; 19(1):74. PubMed ID: 30922230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of N-terminal pro-brain natriuretic peptide with contrast-induced acute kidney injury and long-term mortality in patients with heart failure and mid-range ejection fraction: An observation study.
    Wang K; Li HL; Chen LL; Bei WJ; Lin KY; Smyth B; Chen SQ; Guo XS; Guo W; Liu YH; Chen PY; Chen JY; Chen KH; Liu Y; Tan N
    Medicine (Baltimore); 2017 Mar; 96(10):e6259. PubMed ID: 28272231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of NT-proBNP in Stable Coronary Artery Disease in Chinese Patients after Percutaneous Coronary Intervention in the Drug-eluting Stent Era.
    Zhao XY; Li JX; Tang XF; Xu JJ; Song Y; Jiang L; Chen J; Song L; Gao LJ; Gao Z; Qiao SB; Yang YJ; Gao RL; Xu B; Yuan JQ
    Biomed Environ Sci; 2018 Dec; 31(12):859-866. PubMed ID: 30636655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated high-sensitivity C-reactive protein combined with procalcitonin predicts high risk of contrast-induced nephropathy after percutaneous coronary intervention.
    Gu G; Yuan X; Zhou Y; Liu D; Cui W
    BMC Cardiovasc Disord; 2019 Jun; 19(1):152. PubMed ID: 31234798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of N-terminal pro-B-type natriuretic peptide in patients with acute coronary syndromes undergoing left main percutaneous coronary intervention.
    Jaberg L; Toggweiler S; Puck M; Frank M; Rufibach K; Lüscher TF; Corti R
    Circ J; 2011; 75(11):2648-53. PubMed ID: 21891968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of N-terminal pro-B-type natriuretic peptide with mortality in elderly (≥80 years) patients undergoing percutaneous coronary intervention.
    Sager R; Keller LS; Stehli J; Jakob P; Michel J; Kasel M; Templin C; Stähli BE
    Catheter Cardiovasc Interv; 2022 Oct; 100(4):535-543. PubMed ID: 36040724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safe contrast volumes for preventing contrast-induced nephropathy in elderly patients with relatively normal renal function during percutaneous coronary intervention.
    Liu Y; Liu YH; Chen JY; Tan N; Zhou YL; Duan CY; Yu DQ; Xie NJ; Li HL; Chen PY
    Medicine (Baltimore); 2015 Mar; 94(12):e615. PubMed ID: 25816028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of early tirofiban administration on N-terminal pro-B-type natriuretic peptide level in patients treated with primary percutaneous coronary intervention.
    Fabris E; Ottervanger JP; Hermanides RS; Ten Berg JM; Sinagra G; Koopmans PC; Giannitsis E; Hamm C; van 't Hof AWJ
    Catheter Cardiovasc Interv; 2019 Apr; 93(5):E293-E297. PubMed ID: 30585388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.